Imaging of normal lung, liver and parotid gland function for radiotherapy

Mike Partridge, Tokihiro Yamamoto, Cai Grau, Morten Høyer, Ludvig Paul Muren

Research output: Contribution to journalArticle

23 Citations (Scopus)

Abstract

There is growing clinical evidence that functional imaging is useful for target volume definition and early assessment of tumour response to external beam radiotherapy. A subject that has perhaps received less attention, but is no less promising, is the application of functional imaging to the prediction or measurement of radiation adverse effects in normal tissues. In this manuscript, we review the current published literature describing the use of positron emission tomography (PET), four-dimensional computed tomography (4D-CT), single photon emission computed tomography (SPECT) and magnetic resonance imaging (MRI) to study normal tissue function in the context of radiotherapy to the lung, liver and head & neck. Published results to date demonstrate that functional imaging can be used to preferentially avoid normal tissues not easily identifiable on solely anatomical images. It is also a potentially very powerful tool for the early detection of radiotherapy-induced normal tissue adverse effects and could provide valuable data for building predictive models of outcome. However, one of the major challenges to building useful predictive models is that, to date, there are very little data available with combined images of normal function, 3D delivered radiation dose and clinical outcomes. Prospective data collection through well-constructed studies which use established morbidity scores is clearly a priority if significant progress is to be made in this area.

Original languageEnglish (US)
Pages (from-to)997-1011
Number of pages15
JournalActa Oncologica
Volume49
Issue number7
DOIs
StatePublished - Oct 2010
Externally publishedYes

Fingerprint

Parotid Gland
Radiotherapy
Four-Dimensional Computed Tomography
Lung
Liver
Radiation Effects
Single-Photon Emission-Computed Tomography
Positron-Emission Tomography
Neck
Head
Magnetic Resonance Imaging
Radiation
Morbidity
Neoplasms

ASJC Scopus subject areas

  • Oncology
  • Radiology Nuclear Medicine and imaging
  • Hematology

Cite this

Imaging of normal lung, liver and parotid gland function for radiotherapy. / Partridge, Mike; Yamamoto, Tokihiro; Grau, Cai; Høyer, Morten; Muren, Ludvig Paul.

In: Acta Oncologica, Vol. 49, No. 7, 10.2010, p. 997-1011.

Research output: Contribution to journalArticle

Partridge, Mike ; Yamamoto, Tokihiro ; Grau, Cai ; Høyer, Morten ; Muren, Ludvig Paul. / Imaging of normal lung, liver and parotid gland function for radiotherapy. In: Acta Oncologica. 2010 ; Vol. 49, No. 7. pp. 997-1011.
@article{86838476ca224603a4d7263384b768ae,
title = "Imaging of normal lung, liver and parotid gland function for radiotherapy",
abstract = "There is growing clinical evidence that functional imaging is useful for target volume definition and early assessment of tumour response to external beam radiotherapy. A subject that has perhaps received less attention, but is no less promising, is the application of functional imaging to the prediction or measurement of radiation adverse effects in normal tissues. In this manuscript, we review the current published literature describing the use of positron emission tomography (PET), four-dimensional computed tomography (4D-CT), single photon emission computed tomography (SPECT) and magnetic resonance imaging (MRI) to study normal tissue function in the context of radiotherapy to the lung, liver and head & neck. Published results to date demonstrate that functional imaging can be used to preferentially avoid normal tissues not easily identifiable on solely anatomical images. It is also a potentially very powerful tool for the early detection of radiotherapy-induced normal tissue adverse effects and could provide valuable data for building predictive models of outcome. However, one of the major challenges to building useful predictive models is that, to date, there are very little data available with combined images of normal function, 3D delivered radiation dose and clinical outcomes. Prospective data collection through well-constructed studies which use established morbidity scores is clearly a priority if significant progress is to be made in this area.",
author = "Mike Partridge and Tokihiro Yamamoto and Cai Grau and Morten H{\o}yer and Muren, {Ludvig Paul}",
year = "2010",
month = "10",
doi = "10.3109/0284186X.2010.504735",
language = "English (US)",
volume = "49",
pages = "997--1011",
journal = "Acta Oncologica",
issn = "0284-186X",
publisher = "Informa Healthcare",
number = "7",

}

TY - JOUR

T1 - Imaging of normal lung, liver and parotid gland function for radiotherapy

AU - Partridge, Mike

AU - Yamamoto, Tokihiro

AU - Grau, Cai

AU - Høyer, Morten

AU - Muren, Ludvig Paul

PY - 2010/10

Y1 - 2010/10

N2 - There is growing clinical evidence that functional imaging is useful for target volume definition and early assessment of tumour response to external beam radiotherapy. A subject that has perhaps received less attention, but is no less promising, is the application of functional imaging to the prediction or measurement of radiation adverse effects in normal tissues. In this manuscript, we review the current published literature describing the use of positron emission tomography (PET), four-dimensional computed tomography (4D-CT), single photon emission computed tomography (SPECT) and magnetic resonance imaging (MRI) to study normal tissue function in the context of radiotherapy to the lung, liver and head & neck. Published results to date demonstrate that functional imaging can be used to preferentially avoid normal tissues not easily identifiable on solely anatomical images. It is also a potentially very powerful tool for the early detection of radiotherapy-induced normal tissue adverse effects and could provide valuable data for building predictive models of outcome. However, one of the major challenges to building useful predictive models is that, to date, there are very little data available with combined images of normal function, 3D delivered radiation dose and clinical outcomes. Prospective data collection through well-constructed studies which use established morbidity scores is clearly a priority if significant progress is to be made in this area.

AB - There is growing clinical evidence that functional imaging is useful for target volume definition and early assessment of tumour response to external beam radiotherapy. A subject that has perhaps received less attention, but is no less promising, is the application of functional imaging to the prediction or measurement of radiation adverse effects in normal tissues. In this manuscript, we review the current published literature describing the use of positron emission tomography (PET), four-dimensional computed tomography (4D-CT), single photon emission computed tomography (SPECT) and magnetic resonance imaging (MRI) to study normal tissue function in the context of radiotherapy to the lung, liver and head & neck. Published results to date demonstrate that functional imaging can be used to preferentially avoid normal tissues not easily identifiable on solely anatomical images. It is also a potentially very powerful tool for the early detection of radiotherapy-induced normal tissue adverse effects and could provide valuable data for building predictive models of outcome. However, one of the major challenges to building useful predictive models is that, to date, there are very little data available with combined images of normal function, 3D delivered radiation dose and clinical outcomes. Prospective data collection through well-constructed studies which use established morbidity scores is clearly a priority if significant progress is to be made in this area.

UR - http://www.scopus.com/inward/record.url?scp=77956604452&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=77956604452&partnerID=8YFLogxK

U2 - 10.3109/0284186X.2010.504735

DO - 10.3109/0284186X.2010.504735

M3 - Article

C2 - 20831488

AN - SCOPUS:77956604452

VL - 49

SP - 997

EP - 1011

JO - Acta Oncologica

JF - Acta Oncologica

SN - 0284-186X

IS - 7

ER -